Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111269158A reveals a green dimerization route for alpha-hydroxy acid esters, offering high purity and reduced waste for pharmaceutical intermediate manufacturing.
Patent CN114890913B reveals a high-yield synthesis of dicyanoethyl cyclohexylamine using recyclable acidic ionic liquids, ensuring ultra-low acid content for downstream hydrogenation.
Patent CN107445786B details a novel MoO3-catalyzed hydrogenation of dibenzofuran to biphenyl, offering superior selectivity and cost-effective manufacturing for global supply chains.
Patent CN106243111A details robust synthesis for E1 inhibitors. Offers high purity and scalable routes for pharmaceutical intermediate manufacturing supply chains.
Novel visible-light method for 1,2-allenyl ketones offering mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply chains.
New patent route for Trabectedin intermediates reduces steps and cost. Scalable synthesis from L-tyrosine ensures supply chain stability for global pharma.
Patent CN1380299A reveals a crystallization method replacing column chromatography for purifying nucleoside intermediates, offering significant cost and scalability advantages.
Patent CN104710315A reveals ionic liquid microwave method. High yield, eco-friendly. Reliable supply chain partner for pharmaceutical intermediates.
Patent CN116789555B enables continuous production of high-purity intermediates. This process offers substantial supply chain reliability and cost reduction advantages.
Novel epoxidation method for valiolamine intermediate reduces solvent toxicity and improves yield. Reliable supply chain partner for high-purity pharmaceutical intermediates.
Patent CN1244588C details a novel PDC oxidation route for C10 sugars from xylose, offering cost-effective antiviral intermediate synthesis.
Patent CN103214452B details a novel iron-mediated reduction route for duloxetine intermediates offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel ruthenium catalyst method for ceramide intermediates. High stereoselectivity and reduced reaction time for supply chain efficiency.
Patent CN111203276B reveals a manganese-catalyzed hydrosilylation method for high-purity chiral silanes, offering significant cost reduction and supply chain stability for pharmaceutical intermediates.
Novel synthesis method for acyl ester polycyclic compounds ensures high purity and industrial scalability for global pharmaceutical supply chains.
Patent CN105646675B details efficient solid-phase synthesis of Coibamide A analogues. Enhances yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN118955625A reveals segmented synthesis for HER2 targeting peptide. Enhances purity and yield for scalable pharmaceutical intermediates manufacturing.
Patent CN116237068A reveals an iodine-catalyzed route for 2-phosphonomethyl phenols, offering high atom economy and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN114480315B reveals a novel Baeyer-Villiger monooxygenase route for brivaracetam synthesis offering high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106083793B reveals a one-pot synthesis for 7-methoxyflavone. This method offers high purity, recyclable catalysts, and significant supply chain cost advantages.